PTGS2 and COVID-19: Recently, hesperetin has gained attention for its potential anti-COVID-19 activity, with several studies suggesting that it could be used not only as an anti-COVID-19 agent but also as a preventative measure against cancer by inhibiting key signaling pathways, particularly COX-2 inhibition.